S2Medical AB (publ) (STO:S2M)

Market Cap	4.72M -77.1%
Revenue (ttm)	16.13M +9.9%
Net Income	-10.09M
EPS	-0.01
Shares Out	906.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	372,542
Open	0.0050
Previous Close	0.0052
Day's Range	0.0050 - 0.0050
52-Week Range	0.0042 - 0.0223
Beta	2.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2013
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: S2M